Antigonococcal Activity of (+)-Medicarpin

Area of Science:

• Natural Products Chemistry
• Microbiology
• Pharmacology

Background:

• Antibiotic resistance in Neisseria gonorrhoeae poses a significant global health threat.
• Propolis, a natural resinous mixture, possesses known antimicrobial properties due to its diverse secondary metabolites.
• Novel therapeutic agents are urgently required to combat resistant strains of gonorrhea.

Purpose of the Study:

• To evaluate the antibacterial activity of Jamaican multifloral propolis against Neisseria gonorrhoeae.
• To isolate and identify bioactive compounds from the propolis extract responsible for antibacterial effects.
• To determine the efficacy of isolated compounds against N. gonorrhoeae, including potential synergistic effects.

Main Methods:

• Bioassay-guided fractionation of a Jamaican multifloral propolis ethyl acetate extract.
• Structure elucidation of the isolated compound using spectral analysis and comparison with known metabolites.
• Determination of the minimum inhibitory concentration (MIC) of the isolated compound against N. gonorrhoeae.
• Evaluation of the combined effect of the compound and vancomycin against N. gonorrhoeae.

Main Results:

• (+)-Medicarpin was isolated and identified from the propolis extract.
• Compound (1) demonstrated selective inhibition of N. gonorrhoeae with a minimum inhibitory concentration of 0.25 mg/mL.
• An additive antibacterial effect was observed when (+)-medicarpin was combined with vancomycin.

Conclusions:

• Jamaican multifloral propolis contains compounds with significant antibacterial activity against Neisseria gonorrhoeae.
• (+)-Medicarpin is a promising candidate for further development as a therapeutic agent against gonorrhea.
• The synergistic potential with existing antibiotics like vancomycin warrants further investigation for combination therapies.